Atlas Trials

Real-World Study of Intravitreal Aflibercept 8 mg in Pretreated Eyes With nAMD or DME

Clinical trial NCT07761039 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07761039
Sponsor
Grupo de Estudos da Retina
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
nAMDDME
Start date
2026-09-01
Primary completion
2027-09-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.